NITRIC-OXIDE AND ENDOTHELIN IN PATHOPHYSIOLOGICAL SETTINGS

被引:42
作者
HUNLEY, TE [1 ]
IWASAKI, S [1 ]
HOMMA, T [1 ]
KON, V [1 ]
机构
[1] VANDERBILT UNIV,SCH MED,DEPT PEDIAT,DIV NEPHROL,NASHVILLE,TN 37232
关键词
ENDOTHELIN; ENDOTHELIN RECEPTORS; NITRIC OXIDE; ENDOTHELIUM;
D O I
10.1007/BF00860758
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The role of the endothelium is now known to encompass the generation of many potent cytokines which impact endothelial cells, adjacent tissue such as smooth muscle cells, and distant sites in an autocrine, paracrine, and endocrine manner, respectively. This review addresses two of these cytokines, nitric oxide and endothelin, and describes how each effects the functions of endothelial cells, including regulation of platelet aggregation and coagulation, regulation of vasomotor tone, modulation of inflammation, and the regulation of cellular proliferation. The emphasis is on the increasingly recognized importance of the autocrine and paracrine mechanisms by which nitric oxide and endothelin act. In particular, autoinduction of endothelin is proposed as a central mechanism underlying endothelin's renowned effects. Additionally, specific nitric oxide/endothelin interactions are discussed by which each cytokine modulates the production and actions of the other. The net effect observed in a variety of physiological and pathophysiological settings, therefore, reflects a balance of these opposing functions.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 98 条
[1]  
Engelberg H., Endothelium in health and disease, Semin Thromb Hemost, 15, pp. 178-183, (1989)
[2]  
Kaiser L., Sparks H.V., Endothelial cells: not just a cel-Jophane wrapper, Arch Intern Med, 147, pp. 569-573, (1987)
[3]  
Furchgott R.F., Zawadzki J.W., The obligatory role of endothelial cells in the relaxation of vascular smooth muscle by acetylcholine, Nature, 286, pp. 373-376, (1980)
[4]  
Palmer R.M.J., Ferrige A.G., Moncada S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 286, pp. 524-526, (1987)
[5]  
Feelisch M., te Poel M., Zamora R., Deussen A., Moncada S., Understanding the controversy over the identity of EDRF, Nature, 368, pp. 62-65, (1994)
[6]  
Forstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., Kleinert H., Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions, Hypertension, 23, pp. 1121-1131, (1994)
[7]  
Hibbs J.B., Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R.L., Ward J.H., Menlove R.L., McMurray M.P., Kushner J.P., Samlowski W., Evidence for cytokine-inducible nitric oxide synthesis from l-arginine in patients receiving interleukin-2 therapy, J Clin Invest, 89, pp. 867-877, (1992)
[8]  
Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., Madariaga J., Simmons R.L., Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin, J Exp Med, 176, pp. 261-264, (1992)
[9]  
Denis M., Tumor necrosis factor and granulocyte macrophage colony-stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates, J Leukoc Biol, 49, pp. 380-387, (1991)
[10]  
Busse R., Mulsch A., Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells, FEBS Lett, 275, pp. 87-90, (1990)